New insights in segmental vitiligo: Case report and review of theories

British Journal of Dermatology

Volumn 166, Issue 2, 2012, Pages 240-246

  Van Geel, N ^a   Mollet, I ^a   Brochez, L ^a   Dutre M ^a   De Schepper, S ^a   Verhaeghe, E ^a   Lambert, J ^a   Speeckaert, R ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETAMETHASONE DIPROPIONATE; CALCITONIN; CUTANEOUS LYMPHOCYTE ASSOCIATED ANTIGEN; NERVE GROWTH FACTOR;

ADULT; ALLERGIC RHINITIS; ALOPECIA AREATA; CASE REPORT; CENTRAL NERVOUS SYSTEM; DISEASE DURATION; FAMILY HISTORY; HALO NEVUS; HUMAN; MALE; MELANOCYTE; MOSAICISM; PRIORITY JOURNAL; PSORIASIS; REVIEW; SEGMENTAL VITILIGO; VITILIGO;

ADULT; ALOPECIA AREATA; AUTOIMMUNE DISEASES; HUMANS; MALE; MOSAICISM; NERVOUS SYSTEM DISEASES; NEVUS, HALO; PSORIASIS; SKIN DISEASES, VASCULAR; VITILIGO;

EID: 84856225216     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10650.x     Document Type: Review

References (31)

1. el-Mofty AM, el-Mofty M,. Vitiligo. A symptom complex. Int J Dermatol 1980; 19: 237-44.
2. Koga M, Tango T,. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988; 118: 223-8.
3. van den Boorn JG, Konijnenberg D, Dellemijn TA, et al. Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients. J Invest Dermatol 2009; 129: 2220-32.
4. Speeckaert R, van Geel N, Vermaelen KV, et al. Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy. Pigment Cell Melanoma Res 2011; 24: 334-44.
5. van Geel N, De Lille S, Vandenhaute S, et al. Different phenotypes of segmental vitiligo based on a clinical observational study. J Eur Acad Dermatol Venereol 2010; 25: 673-8.
6. Sardana K, Sharma RC, Koranne RV, et al. An interesting case of colocalization of segmental lichen planus and vitiligo in a 14-year-old boy. Int J Dermatol 2002; 41: 508-9.
7. Weisberg EL, Le LQ, Cohen JB,. A case of simultaneously occurring lichen sclerosus and segmental vitiligo: connecting the underlying autoimmune pathogenesis. Int J Dermatol 2008; 47: 1053-5.
8. Muramatsu S, Suga Y, Mizuno Y, et al. A Japanese case of naevoid basal cell carcinoma syndrome associated with segmental vitiligo. Br J Dermatol 2005; 152: 812-14.
9. Creus L, Sanchez-Regana M, Salleras M, et al. [Parry-Romberg syndrome associated with homolateral segmental vitiligo]. Ann Dermatol Venereol 1994; 121: 710-11.
10. Bonifati C, Impara G, Morrone A, et al. Simultaneous occurrence of linear scleroderma and homolateral segmental vitiligo. J Eur Acad Dermatol Venereol 2006; 20: 63-5.
11. Koga M,. Vitiligo: a new classification and therapy. Br J Dermatol 1977; 97: 255-61.
12. Taieb A, Morice-Picard F, Jouary T, et al. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res 2008; 21: 646-52.
13. van Geel NA, Mollet IG, De Schepper S, et al. First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi. Pigment Cell Melanoma Res 2010; 23: 375-84.
14. Nelhaus G,. Acquired unilateral vitiligo and poliosis of the head and subacute encephalitis with partial recovery. Neurology 1970; 20: 965-74.
15. Wu CS, Yu HS, Chang HR, et al. Cutaneous blood flow and adrenoceptor response increase in segmental-type vitiligo lesions. J Dermatol Sci 2000; 23: 53-62.
16. Chapman BP, Moynihan J,. The brain-skin connection: role of psychosocial factors and neuropeptides in psoriasis. Expert Rev Clin Immunol 2009; 5: 623-7.
17. Kalish RS,. Clues from alopecia areata on the role of neuropeptides in the initiation of autoimmunity. J Invest Dermatol 2007; 127: 1289-91.
18. Gilhar A, Paus R, Kalish RS,. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019-27.
19. Jessop DS,. Brain-immune interactions in arthritis: an integrated systems approach. Arthritis Rheum 2008; 58: 2928-30.
20. Molho-Pessach V, Schaffer JV,. Blaschko lines and other patterns of cutaneous mosaicism. Clin Dermatol 2011; 29: 205-25.
21. Happle R,. Superimposed segmental manifestation of polygenic skin disorders. J Am Acad Dermatol 2007; 57: 690-9.
22. van Geel N, Wallaeys E, Goh BK, et al. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus. Br J Dermatol 2010; 163: 1186-93.
23. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, et al. Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. Lab Invest 2000; 80: 1299-309.
24. Westerhof W, d'Ischia M,. Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 2007; 20: 345-59.
25. Seitz CS, Garbaraviciene J, Brocker EB, et al. Superimposed linear psoriasis: differential therapeutic response of linear and nonlinear lesions. Clin Exp Dermatol 2009; 34: e177-9.
26. Ezzedine K, Gauthier Y, Léauté-Labrèze C, et al. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol 2011; 65: 965-71.
27. Hann SK, Lee HJ,. Segmental vitiligo: clinical findings in 208 patients. J Am Acad Dermatol 1996; 35: 671-4.
28. Barona MI, Arrunategui A, Falabella R, et al. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol 1995; 33: 621-5.
29. Hendrix S, Peters EM,. Neuronal plasticity and neuroregeneration in the skin-the role of inflammation. J Neuroimmunol 2007; 184: 113-26.
30. Westerhof W, Manini P, Napolitano A, et al. The haptenation theory of vitiligo and melanoma rejection: a close-up. Exp Dermatol 2011; 20: 92-6.
31. Le Poole IC, Das PK, van den Wijngaard RM, et al. Review of the etiopathomechanism of vitiligo: a convergence theory. Exp Dermatol 1993; 2: 145-53.